Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
Syneron to acquire TransPharma Medical (transdermal drug delivery technology) for $3.6 million
firstwordmedtech.com/node/933001 via @fwmedtech
Allergan confirms US judge’s decision to issue permanent injunction against Merz over Botox rival. #Xeomin #Bocouture
firstwordpharma.com/node/959359
Still-Experimental Laser Device May Detect Melanoma in its Earliest Stages. #SkinCancer
plasticsurgerypractice.com/eReport/2012-0…
Reasoning and evidence-based medicine: common pitfalls.
ncbi.nlm.nih.gov/pubmed/22392214
Rhinoplasty in Indian Americans Requires Unique Considerations
rileycre.temporaryurl.biz/miinews/2012/0…
Rethinking the Body and Its Boundaries. Regenerative medicine
rileycre.temporaryurl.biz/miinews/2012/0…
Allergan Wins U.S. Court Order Blocking Sales of Xeomin. #Botox Merz
rileycre.temporaryurl.biz/miinews/2012/0…
For skin rejuvenation Experts emphasize importance of preventive Tx
rileycre.temporaryurl.biz/miinews/2012/0…
FDA approves Sientra’s breast implants. With 3 years of clinical data involving 1788 patients + 7 years follow up.
firstwordmedtech.com/node/932987
@thibaudguymard have you heard about digital remedies?
remedes-numeriques.com/Welcome-to-the…